Search Legislation

The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

Changes over time for: Section 10

 Help about opening options

Alternative versions:

Changes to legislation:

There are currently no known outstanding effects for the The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Section 10. Help about Changes to Legislation

Amendment of regulation 21 (clinical trials conducted in third countries)U.K.

This section has no associated Explanatory Memorandum

10.—(1) Regulation 21 is amended as follows.

(2) In the heading, for “third countries” substitute “ countries other than the United Kingdom ”.

(3) In paragraph (1), for “a third” substitute “ another ”.

Commencement Information

I1Reg. 10 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Back to top

Options/Help